A recent study by researchers in New York, USA, and published in Clinical Genitourinary Cancer identified gene alterations and clinical characteristics that could help predict outcome in patients with a rare form of renal cell carcinoma (RCC) called chromophobe RCC. These gene alterations and clinical characteristics could also help identify potential targeted therapy options in the future, as well as predict treatment outcome.

However, they only identified 18 patients to analyse from a comprehensive Cancer Genome Atlas Database, which collates information from a number of different institutions in the US. Therefore, these gene profiles and clinical characteristics will require further validation.

Read more in UroToday here